The Bawmann Group Acquires Ubiquity Group

The Bawmann Group Acquires Ubiquity Group

Posted by tbg | November 1, 2014 | TBG Wired Blog

The Bawmann Group and Ubiquity Group Join Forces to Form a Powerful New Agency

The Bawmann Group (TBG) is thrilled to announce that we have expanded our services with the acquisition of Denver-based Ubiquity Group, which specializes in biotech and medical technology marketing. The acquisition is effective immediately.

The combined TBG-Ubiquity team will continue to serve a wide range of clients, maintaining our high-quality work for premier health care and biotech companies as well as nonprofit organizations, private businesses and other industry innovators.

This acquisition enhances TBG’s expansive list of services, which run from branding, advertising and web development to media relations and issues management.

According to Brad Bawmman, TBG president and CEO, “We are blessed to be able to grow our team with the addition of Ubiquity’s talented professionals and significant international client base. Our existing clients will benefit from Ubiquity’s creative team, and Ubiquity’s clients will have access to a broader range of integrated marketing expertise, including public relations, crisis communication and social media services.”

For nearly 20 years, TBG has helped organizations around the world achieve their marketing objectives across a variety of audiences. We have worked in virtually all segments of the health care system, serving governmental agencies, insurance companies, health care providers, hospital systems, foundations, medical researchers, biotechnology and pharmaceutical companies, private businesses and other key health care stakeholders to execute impactful, efficient and effective marketing initiatives.

“What impresses me about TBG is its ability to adapt very quickly,” said Lisa Stemmer, Ubiquity Group founder and chief strategy officer. “I truly believe Ubiquity Group’s clients will thrive with more communication options, and TBG’s clients will benefit greatly from our creative team.”

Stemmer will stay on with TBG as a senior advisor and focus her work on cultivating our European client base.

Ubiquity has helped biotech and medical technology clients achieve and surpass their marketing goals for 14 years. It has worked with prominent national and international companies as well as businesses based in Colorado’s health care, biotech and medical device sectors.

Ubiquity’s work includes marketing strategy, websites, mobile apps, interactive presentations, video, print collateral and email campaigns.

The new, more robust TBG will now expand our business even further into the health care, medical technology and biotech fields while continuing to grow our lively practices in a wide array of other industries.

Learn more about the faces of TBG here.

Click here to find out more about what TBG can do for you. Or, email Brad to see how we can help accomplish your goals.